MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications

Research output: Contribution to journalReview articlepeer-review

92 Scopus citations


MicroRNAs (miRNAs) are a group of small non-coding RNA molecules of 17-25 nucleotides (nt) in length, predicted to control the activity of about 30% of all protein-coding genes in mammals. Altered expressions of miRNAs are reported in various cancers and may associate with cancer pathogenesis, apoptosis, and cell growth, thereby functioning as either tumor suppressors or oncogenes. Recent reports showed that deregulation of miRNA contribute to tumor development and progression and hence, have diagnostic and prognostic value in several human malignancies. This review discusses the current status of miRNA in pancreatic cancer development, progression, diagnosis, and therapy.

Original languageEnglish (US)
Pages (from-to)8-16
Number of pages9
JournalCancer Letters
Issue number1
StatePublished - Jun 2010


  • Diagnosis and therapy
  • MicroRNA
  • Pancreatic cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications'. Together they form a unique fingerprint.

Cite this